These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25155875)

  • 1. DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders.
    Möller HJ; Bandelow B; Bauer M; Hampel H; Herpertz SC; Soyka M; Barnikol UB; Lista S; Severus E; Maier W
    Eur Arch Psychiatry Clin Neurosci; 2015 Mar; 265(2):87-106. PubMed ID: 25155875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences--part 1: general aspects and paradigmatic discussion of depressive disorders.
    Möller HJ; Bandelow B; Bauer M; Hampel H; Herpertz SC; Soyka M; Barnikol UB; Lista S; Severus E; Maier W
    Eur Arch Psychiatry Clin Neurosci; 2015 Feb; 265(1):5-18. PubMed ID: 25119146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The consequences of DSM-5 for psychiatric diagnosis and psychopharmacotherapy.
    Möller HJ
    Int J Psychiatry Clin Pract; 2014 Jun; 18(2):78-85. PubMed ID: 24494777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DSM 5 and child psychiatric disorders: what is new? What has changed?
    Eapen V; Črnčec R
    Asian J Psychiatr; 2014 Oct; 11():114-8. PubMed ID: 25453713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in psychiatric diagnostic classification.
    Allsopp K; Read J; Corcoran R; Kinderman P
    Psychiatry Res; 2019 Sep; 279():15-22. PubMed ID: 31279246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current viewpoints on DSM-5 in Japan.
    Kuroki T; Ishitobi M; Kamio Y; Sugihara G; Murai T; Motomura K; Ogasawara K; Kimura H; Aleksic B; Ozaki N; Nakao T; Yamada K; Yoshiuchi K; Kiriike N; Ishikawa T; Kubo C; Matsunaga C; Miyata H; Asada T; Kanba S
    Psychiatry Clin Neurosci; 2016 Sep; 70(9):371-93. PubMed ID: 27414748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight across mental disorders: A multifaceted metacognitive phenomenon.
    Konstantakopoulos G
    Psychiatriki; 2019; 30(1):13-16. PubMed ID: 31115349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Externalizing psychopathology in adulthood: a dimensional-spectrum conceptualization and its implications for DSM-V.
    Krueger RF; Markon KE; Patrick CJ; Iacono WG
    J Abnorm Psychol; 2005 Nov; 114(4):537-50. PubMed ID: 16351376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possibilities and limitations of DSM-5 in improving the classification and diagnosis of mental disorders.
    Möller HJ
    Psychiatr Pol; 2018 Aug; 52(4):611-628. PubMed ID: 30368532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DSM categories and dimensions in clinical and research contexts.
    Kraemer HC
    Int J Methods Psychiatr Res; 2007; 16 Suppl 1(Suppl 1):S8-S15. PubMed ID: 17623398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Revision and 5th Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5): Consequences for the Diagnostic Work with Children and Adolescents].
    Zulauf Logoz M
    Prax Kinderpsychol Kinderpsychiatr; 2014; 63(7):562-76. PubMed ID: 25478714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of a research agenda for substance use disorders diagnosis in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V).
    Saunders JB; Schuckit MA
    Addiction; 2006 Sep; 101 Suppl 1():1-5. PubMed ID: 16930155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should there be both categorical and dimensional criteria for the substance use disorders in DSM-V?
    Helzer JE; van den Brink W; Guth SE
    Addiction; 2006 Sep; 101 Suppl 1():17-22. PubMed ID: 16930157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimensional approaches to psychiatric diagnosis in DSM-5.
    Narrow WE; Kuhl EA
    J Ment Health Policy Econ; 2011 Dec; 14(4):197-200. PubMed ID: 22345361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DSM-5 and Mental Disorders in Older Individuals: An Overview.
    Sachdev PS; Mohan A; Taylor L; Jeste DV
    Harv Rev Psychiatry; 2015; 23(5):320-8. PubMed ID: 26332215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An approach to DSM-5: a breakthrough in psychiatry?].
    Heerlein AL
    Vertex; 2014; 25(113):18-26. PubMed ID: 24887365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of Psychiatric Disorders.
    Kim YK; Park SC
    Adv Exp Med Biol; 2019; 1192():17-25. PubMed ID: 31705488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DSM-ICD diagnostic approach as an essential bridge between the patient and the "big data".
    Mitropoulos GB
    Psychiatriki; 2018; 29(3):249-256. PubMed ID: 30605429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Male and female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria.
    Fishbain DA; Goldberg M; Meagher RB; Steele R; Rosomoff H
    Pain; 1986 Aug; 26(2):181-197. PubMed ID: 3763232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.